These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 29972208)
1. Commentary: Fatty acids and Alzheimer's disease: evidence on cognition and cortical β-amyloid from secondary analyses of the Multidomain Alzheimer Preventive Trial. Hooper C; Vellas B J Prev Alzheimers Dis; 2018; 5(3):168-170. PubMed ID: 29972208 [No Abstract] [Full Text] [Related]
2. Cortical β-Amyloid in Older Adults Is Associated with Multidomain Interventions with and without Omega 3 Polyunsaturated Fatty Acid Supplementation. Hooper C; Coley N; De Souto Barreto P; Payoux P; Salabert AS; Andrieu S; Weiner M; Vellas B J Prev Alzheimers Dis; 2020; 7(2):128-134. PubMed ID: 32236402 [TBL] [Abstract][Full Text] [Related]
3. Cross-Sectional Associations of Total Plasma Homocysteine with Cortical β-Amyloid Independently and as a Function of Omega 3 Polyunsaturated Fatty Acid Status in Older Adults at Risk of Dementia. Hooper C; De Souto Barreto P; Coley N; Caussé E; Payoux P; Salabert AS; Cesari M; Andrieu S; Bowman GL; Weiner M; Vellas B J Nutr Health Aging; 2017; 21(10):1075-1080. PubMed ID: 29188863 [TBL] [Abstract][Full Text] [Related]
5. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Gillette-Guyonnet S; Andrieu S; Dantoine T; Dartigues JF; Touchon J; Vellas B; Alzheimers Dement; 2009 Mar; 5(2):114-21. PubMed ID: 19328438 [TBL] [Abstract][Full Text] [Related]
6. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756 [TBL] [Abstract][Full Text] [Related]
7. Effects of omega-3 fatty acids on cognitive function with aging, dementia, and neurological diseases. Maclean CH; Issa AM; Newberry SJ; Mojica WA; Morton SC; Garland RH; Hilton LG; Traina SB; Shekelle PG Evid Rep Technol Assess (Summ); 2005 Feb; (114):1-3. PubMed ID: 15777112 [No Abstract] [Full Text] [Related]
8. Effects of multidomain lifestyle intervention, omega-3 supplementation or their combination on physical activity levels in older adults: secondary analysis of the Multidomain Alzheimer Preventive Trial (MAPT) randomised controlled trial. Barreto PS; Rolland Y; Cesari M; Dupuy C; Andrieu S; Vellas B; Age Ageing; 2018 Mar; 47(2):281-288. PubMed ID: 29136094 [TBL] [Abstract][Full Text] [Related]
9. Multidomain intervention and/or omega-3 in nondemented elderly subjects according to amyloid status. Delrieu J; Payoux P; Carrié I; Cantet C; Weiner M; Vellas B; Andrieu S Alzheimers Dement; 2019 Nov; 15(11):1392-1401. PubMed ID: 31558366 [TBL] [Abstract][Full Text] [Related]
10. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease. Oh H; Madison C; Baker S; Rabinovici G; Jagust W Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008 [TBL] [Abstract][Full Text] [Related]
11. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B; Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749 [TBL] [Abstract][Full Text] [Related]
12. Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease. Baker-Nigh A; Vahedi S; Davis EG; Weintraub S; Bigio EH; Klein WL; Geula C Brain; 2015 Jun; 138(Pt 6):1722-37. PubMed ID: 25732182 [TBL] [Abstract][Full Text] [Related]
13. Enriched endogenous n-3 polyunsaturated fatty acids alleviate cognitive and behavioral deficits in a mice model of Alzheimer's disease. Wu K; Gao X; Shi B; Chen S; Zhou X; Li Z; Gan Y; Cui L; Kang JX; Li W; Huang R Neuroscience; 2016 Oct; 333():345-55. PubMed ID: 27474225 [TBL] [Abstract][Full Text] [Related]
14. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease. Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487 [TBL] [Abstract][Full Text] [Related]
15. Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial. Delrieu J; Vellas B; Guyonnet S; Cantet C; Ovod V; Li Y; Bollinger J; Bateman R; Andrieu S; Alzheimers Res Ther; 2023 Oct; 15(1):183. PubMed ID: 37872582 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model. Paban V; Manrique C; Filali M; Maunoir-Regimbal S; Fauvelle F; Alescio-Lautier B Neuropharmacology; 2014 Jan; 76 Pt A():68-79. PubMed ID: 23891615 [TBL] [Abstract][Full Text] [Related]
17. [Contribution of omega-3 fatty acids for memory and cognitive function]. Waitzberg DL; Garla P Nutr Hosp; 2014 Sep; 30(3):467-77. PubMed ID: 25238820 [TBL] [Abstract][Full Text] [Related]